title: [Experience on the use of sugammadex in a French university hospital].
authors.forename: K
authors.initials: K
authors.lastname: Beny
authors.forename: A-F
authors.initials: AF
authors.lastname: Mirabaud
authors.forename: V
authors.initials: V
authors.lastname: Piriou
authors.forename: G
authors.initials: G
authors.lastname: Aulagner
authors.forename: X
authors.initials: X
authors.lastname: Armoiry
mesh_terms: D000368:Aged; D000732:Androstanols / Q000037:antagonists & inhibitors; D000768:Anesthesia, General; D001279:Atracurium / Q000031:analogs & derivatives; D004363:Drug Utilization; D005260:Female; D005602:France; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D019148:Neuromuscular Blockade; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D000077123:Rocuronium; D013390:Succinylcholine; D000077122:Sugammadex; D014673:Vecuronium Bromide; D047408:gamma-Cyclodextrins
chemical_list: D000732:Androstanols; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D001279:Atracurium; D000077122:Sugammadex; D014673:Vecuronium Bromide; D013390:Succinylcholine; C101584:cisatracurium; D000077123:Rocuronium